NCT00371995View on ClinicalTrials.gov

Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

February 28, 2010

Conditions
Visceral Leishmaniasis
Interventions
DRUG

Liposomal amphotericin B and Miltefosine

"Liposomal amphotericin B administered intravenously as single dose on day 1, Dosage: 5 mg/kg.~Miltefosine administered orally (50 mg capsules) for 14 days (on days 2-15)"

Trial Locations (2)

842001

Kala-azar Medical Research Center, Muzaffarpur

Unknown

Rajendra Memorial Research Institute of Medical Sciences, Patna

All Listed Sponsors
collaborator

Rajendra Memorial Research Institute of Medical Sciences

OTHER

lead

Banaras Hindu University

OTHER

NCT00371995 - Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar | Biotech Hunter | Biotech Hunter